- Pioneering
supplier-to-pharmacy tech platform builder Trxade Group Inc. helps small,
community-based pharmaceutical businesses be competitive with larger
chains by sourcing drugs at discount prices and promoting transparency in
business operations
- Trxade
Group has been developing its subscribers’ access to licensed medical
professionals through telehealth services that are both convenient to the
patient and significant in their ability to limit the number of people
visiting hospitals and offices
- Amid
the sweeping, deadly impact of the seasonal flu and the rising novel
coronavirus epidemic, Trxade’s online access to physicians is a timely
preventative service
- Trxade
Group Inc. recently announced its uplisting to the Nasdaq Capital Market
and rang the exchange’s opening bell, changing its ticker from ‘TRXD’ to
‘MEDS’
- The
company’s network of pharmaceutical partners continues to grow, serving a
large percentage of the nation’s 24,000 independent pharmacies
Innovative B2B health services provider Trxade Group Inc. (NASDAQ: MEDS) is helping to reduce
exposure to deadly viruses sweeping the planet through the patient empowerment
actions of its wholly owned subsidiaries.
As seasonal flu virus infections continue to claim the lives
of tens of thousands of Americans and hospitalizes hundreds of thousands of
people worldwide (http://ibn.fm/svaWn),
the rise and spread of the novel coronavirus COVID-19 has drawn attention to
international measures to stop a deadly, vaccine-less illness by first locking
down an entire province (in China), and most recently an entire nation (in
Italy), while other communities worldwide close public gathering venues or
attempt to assure attendees that adequate health measures are being taken to
limit their exposure to such viruses (http://ibn.fm/8m08C).
Trxade Group’s support of community-based, independent
pharmacies, as well as the acquisition of Community Specialty Pharmacy’s online
access operation last year (http://ibn.fm/w1vWg)
and the establishment of the “Bonum Health Hub” online portal initiative this
year (http://ibn.fm/M2SBE)
seems almost prescient in nature given the viral outbreaks’ impact even on
access to hospital facilities and their providers (http://ibn.fm/HSCXs).
On March 10, Trxade Group announced the launch of a new membership
service by its virtual healthcare subsidiary Bonum Health and its DelivMeds
concierge medication delivery operation. The new service allows subscribers to
obtain three premium medical teleconferencing visits and free prescription
delivery per month, according to a company news release (http://ibn.fm/BDhhl).
Bonum’s telehealth services utilize patients’ personal smart
tech devices in a private, HIPPA compliant manner that delivers access to
board-certified physicians from virtually anywhere the patient may choose to
be.
“Teleconferencing with a board-certified provider for
assurance via online consultation is quick, easy, and relatively inexpensive.
These services free patients from unnecessary exposure or resorting to urgent
care facilities and hospital emergency rooms,” Trxade Group’s news release
states. “With the seasonal flu outbreaks and the current coronavirus surge,
patients are quick to brush off common symptoms, including cough, fever and body
aches, as signs of a common cold; Telemedicine removes the barrier of
self-doubt and complacency in the current climate of world-wide viral
infections.”
Trxade Group is building a growing platform of integrated
drug procurement, delivery and healthcare services to facilitate price
transparency and increased profit margins for independent pharmacies within its
network as well as pharmaceutical product sellers.
The company recently uplisted its common stock to the Nasdaq
Capital Market, while also announcing it expected gross proceeds of $5.2
million from the sale of common stock in a public offering (http://ibn.fm/Nr5uo).
For more information, visit the company’s website at www.TrxadeGroup.com
NOTE TO INVESTORS: The latest news and updates
relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless
communications programs to address the needs of companies ranging from
start-ups to established industry leaders, gaining valuable experience and the
expertise necessary to determine the most effective strategy for any given
situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
